Abstract:SummaryUsing data from the Trauma Audit Research Network, we investigated the costs of acute care in patients ‡ 18 years of age hospitalised for traumatic brain injury between January 2000 and December 2005 in England and Wales. Traumatic brain injury patients were defined and stratified using the Abbreviated Injury Scale. A total of 6484 traumatic brain injury patients were identified; 22.3% had an Abbreviated Injury Scale score of three, 38.0% of four and 39.7% of five. Median age (IQR) was 42 years (28-59) … Show more
“…Previous observational studies, consistent with cost data in HITS-NS, suggest large incremental differences in costs between management in specialist and non-specialist centres. 3,41 Disparities of this magnitude are less likely to be explained by confounding, suggesting that our parameterisation may indeed reflect reality. However, ultimately, evidence from a well-conducted randomised trial is necessary to provide a definitive estimate.…”
Section: Interpretation Of Findingsmentioning
confidence: 92%
“…Each patient with TBI costs an average of £15,000 for acute NHS care, a figure which increases if the patient is admitted to a SNC. 3 Subsequent rehabilitation costs are also significant, but both are dwarfed by costs to society from premature death or lifelong dependency as a young adult. Observational evidence at the time of applying for funding in 2008 suggested that this NHS investment had failed to reduce case fatality from TBI over the 1994-2003 decade, with recent trials of neuroprotective agents failing to identify any single new effective therapy.…”
Section: Relevance Of Hits-ns To the Nhsmentioning
confidence: 99%
“…The interventions include evacuation of intracranial haematoma [subdural haematoma (SDH), extradural haematoma (EDH)], establishment of ICP monitoring and resulting surgical interventions, such as ventriculostomy and decompressive craniectomy. To justify the feasibility analysis, we hypothesised that, should early neurosurgery be shown in a full trial to be cost-effective at absolute 30-day mortality and 6-month severe disability reduction of 5%, the extra costs to the NHS (£17M per annum 3 ) would be offset by the significant economic benefits of reduced morbidity in this young population, which can be estimated from a 5% reduction resulting in 450 fewer TBI deaths and severe disabilities per annum; the annual societal saving, given a conservative estimate of each TBI death or severe disability costing society £250,000 (J Nicholl, University of Sheffield, September 2011, personal communication), would be £117M (£100M after NHS costs) -this excludes the value of any legal settlements.…”
Section: Initial Cost-benefit Estimate For Early Neurosurgerymentioning
confidence: 99%
“…However, the model output appears to have face validity and is not inconsistent with costs and outcomes reported in other broadly related studies. 3,41,111 Finally, there are a number of potential limitations that could affect expected value of information results. These analyses are premised on the implemented decision analysis model and are therefore subject to identical biases arising from model inputs and structure described previously.…”
BackgroundReconfiguration of trauma services, with direct transport of traumatic brain injury (TBI) patients to neuroscience centres (NCs), bypassing non-specialist acute hospitals (NSAHs), could potentially improve outcomes. However, delays in stabilisation of airway, breathing and circulation (ABC) and the difficulties in reliably identifying TBI at scene may make this practice deleterious compared with selective secondary transfer from nearest NSAH to NC. National Institute for Health and Care Excellence guidance and systematic reviews suggested equipoise and poor-quality evidence – with regard to ‘early neurosurgery’ in this cohort – which we sought to address.MethodsPilot cluster randomised controlled trial of bypass to NC conducted in two ambulance services with the ambulance station (n = 74) as unit of cluster [Lancashire/Cumbria in the North West Ambulance Service (NWAS) and the North East Ambulance Service (NEAS)]. Adult patients with signs of isolated TBI [Glasgow Coma Scale (GCS) score of < 13 in NWAS, GCS score of < 14 in NEAS] and stable ABC, injured nearest to a NSAH were transported either to that hospital (control clusters) or bypassed to the nearest NC (intervention clusters). Primary outcomes: recruitment rate, protocol compliance, selection bias as a result of non-compliance, accuracy of paramedic TBI identification (overtriage of study inclusion criteria) and pathway acceptability to patients, families and staff. ‘Open-label’ secondary outcomes: 30-day mortality, 6-month Extended Glasgow Outcome Scale (GOSE) and European Quality of Life-5 Dimensions.ResultsOverall, 56 clusters recruited 293 (169 intervention, 124 control) patients in 12 months, demonstrating cluster randomised pre-hospital trials as viable for heath service evaluations. Overall compliance was 62%, but 90% was achieved in the control arm and when face-to-face paramedic training was possible. Non-compliance appeared to be driven by proximity of the nearest hospital and perceptions of injury severity and so occurred more frequently in the intervention arm, in which the perceived time to the NC was greater and severity of injury was lower. Fewer than 25% of recruited patients had TBI on computed tomography scan (n = 70), with 7% (n = 20) requiring neurosurgery (craniotomy, craniectomy or intracranial pressure monitoring) but a further 18 requiring admission to an intensive care unit. An intention-to-treat analysis revealed the two trial arms to be equivalent in terms of age, GCS and severity of injury. No significant 30-day mortality differences were found (8.8% vs. 9.1/%;p > 0.05) in the 273 (159/113) patients with data available. There were no apparent differences in staff and patient preferences for either pathway, with satisfaction high with both. Very low responses to invitations to consent for follow-up in the large number of mild head injury-enrolled patients meant that only 20% of patients had 6-month outcomes. The trial-based economic evaluation could not focus on early neurosurgery because of these low numbers but instead investigated the comparative cost-effectiveness of bypass compared with selective secondary transfer for eligible patients at the scene of injury.ConclusionsCurrent NHS England practice of bypassing patients with suspected TBI to neuroscience centres gives overtriage ratios of 13 : 1 for neurosurgery and 4 : 1 for TBI. This important finding makes studying the impact of bypass to facilitate early neurosurgery not plausible using this study design. Future research should explore an efficient comparative effectiveness design for evaluating ‘early neurosurgery through bypass’ and address the challenge of reliable TBI diagnosis at the scene of injury.Trial registrationCurrent Controlled Trials ISRCTN68087745.FundingThis project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full inHealth Technology Assessment; Vol. 20, No. 1. See the NIHR Journals Library website for further project information.
“…Previous observational studies, consistent with cost data in HITS-NS, suggest large incremental differences in costs between management in specialist and non-specialist centres. 3,41 Disparities of this magnitude are less likely to be explained by confounding, suggesting that our parameterisation may indeed reflect reality. However, ultimately, evidence from a well-conducted randomised trial is necessary to provide a definitive estimate.…”
Section: Interpretation Of Findingsmentioning
confidence: 92%
“…Each patient with TBI costs an average of £15,000 for acute NHS care, a figure which increases if the patient is admitted to a SNC. 3 Subsequent rehabilitation costs are also significant, but both are dwarfed by costs to society from premature death or lifelong dependency as a young adult. Observational evidence at the time of applying for funding in 2008 suggested that this NHS investment had failed to reduce case fatality from TBI over the 1994-2003 decade, with recent trials of neuroprotective agents failing to identify any single new effective therapy.…”
Section: Relevance Of Hits-ns To the Nhsmentioning
confidence: 99%
“…The interventions include evacuation of intracranial haematoma [subdural haematoma (SDH), extradural haematoma (EDH)], establishment of ICP monitoring and resulting surgical interventions, such as ventriculostomy and decompressive craniectomy. To justify the feasibility analysis, we hypothesised that, should early neurosurgery be shown in a full trial to be cost-effective at absolute 30-day mortality and 6-month severe disability reduction of 5%, the extra costs to the NHS (£17M per annum 3 ) would be offset by the significant economic benefits of reduced morbidity in this young population, which can be estimated from a 5% reduction resulting in 450 fewer TBI deaths and severe disabilities per annum; the annual societal saving, given a conservative estimate of each TBI death or severe disability costing society £250,000 (J Nicholl, University of Sheffield, September 2011, personal communication), would be £117M (£100M after NHS costs) -this excludes the value of any legal settlements.…”
Section: Initial Cost-benefit Estimate For Early Neurosurgerymentioning
confidence: 99%
“…However, the model output appears to have face validity and is not inconsistent with costs and outcomes reported in other broadly related studies. 3,41,111 Finally, there are a number of potential limitations that could affect expected value of information results. These analyses are premised on the implemented decision analysis model and are therefore subject to identical biases arising from model inputs and structure described previously.…”
BackgroundReconfiguration of trauma services, with direct transport of traumatic brain injury (TBI) patients to neuroscience centres (NCs), bypassing non-specialist acute hospitals (NSAHs), could potentially improve outcomes. However, delays in stabilisation of airway, breathing and circulation (ABC) and the difficulties in reliably identifying TBI at scene may make this practice deleterious compared with selective secondary transfer from nearest NSAH to NC. National Institute for Health and Care Excellence guidance and systematic reviews suggested equipoise and poor-quality evidence – with regard to ‘early neurosurgery’ in this cohort – which we sought to address.MethodsPilot cluster randomised controlled trial of bypass to NC conducted in two ambulance services with the ambulance station (n = 74) as unit of cluster [Lancashire/Cumbria in the North West Ambulance Service (NWAS) and the North East Ambulance Service (NEAS)]. Adult patients with signs of isolated TBI [Glasgow Coma Scale (GCS) score of < 13 in NWAS, GCS score of < 14 in NEAS] and stable ABC, injured nearest to a NSAH were transported either to that hospital (control clusters) or bypassed to the nearest NC (intervention clusters). Primary outcomes: recruitment rate, protocol compliance, selection bias as a result of non-compliance, accuracy of paramedic TBI identification (overtriage of study inclusion criteria) and pathway acceptability to patients, families and staff. ‘Open-label’ secondary outcomes: 30-day mortality, 6-month Extended Glasgow Outcome Scale (GOSE) and European Quality of Life-5 Dimensions.ResultsOverall, 56 clusters recruited 293 (169 intervention, 124 control) patients in 12 months, demonstrating cluster randomised pre-hospital trials as viable for heath service evaluations. Overall compliance was 62%, but 90% was achieved in the control arm and when face-to-face paramedic training was possible. Non-compliance appeared to be driven by proximity of the nearest hospital and perceptions of injury severity and so occurred more frequently in the intervention arm, in which the perceived time to the NC was greater and severity of injury was lower. Fewer than 25% of recruited patients had TBI on computed tomography scan (n = 70), with 7% (n = 20) requiring neurosurgery (craniotomy, craniectomy or intracranial pressure monitoring) but a further 18 requiring admission to an intensive care unit. An intention-to-treat analysis revealed the two trial arms to be equivalent in terms of age, GCS and severity of injury. No significant 30-day mortality differences were found (8.8% vs. 9.1/%;p > 0.05) in the 273 (159/113) patients with data available. There were no apparent differences in staff and patient preferences for either pathway, with satisfaction high with both. Very low responses to invitations to consent for follow-up in the large number of mild head injury-enrolled patients meant that only 20% of patients had 6-month outcomes. The trial-based economic evaluation could not focus on early neurosurgery because of these low numbers but instead investigated the comparative cost-effectiveness of bypass compared with selective secondary transfer for eligible patients at the scene of injury.ConclusionsCurrent NHS England practice of bypassing patients with suspected TBI to neuroscience centres gives overtriage ratios of 13 : 1 for neurosurgery and 4 : 1 for TBI. This important finding makes studying the impact of bypass to facilitate early neurosurgery not plausible using this study design. Future research should explore an efficient comparative effectiveness design for evaluating ‘early neurosurgery through bypass’ and address the challenge of reliable TBI diagnosis at the scene of injury.Trial registrationCurrent Controlled Trials ISRCTN68087745.FundingThis project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full inHealth Technology Assessment; Vol. 20, No. 1. See the NIHR Journals Library website for further project information.
“…In developed countries, the annual incidence rates are approximately 200 per 100,000 [1]. The greater the severity of TBI, the greater the economic burden on healthcare providers [2,3], particularly acute care and rehabilitation services.…”
Dysphagia is a common morbidity and cause of mortality following traumatic brain injury (TBI). Despite this, there is a paucity of evidence demonstrating the efficacy of dysphagia management strategies and treatments in this population. Typically, subjects with dysphagia following TBI are placed into non-specific 'neurogenic' dysphagia subject groups, which include subjects with degenerative neurological diseases, neurological cancers, and cerebrovascular accident. However, dysphagia following TBI has a multifactorial presentation, with causative and contributory factors including cognitivecommunication, behavioral, neurological, and mechanical issues. As such, the management for dysphagia post-TBI must be multifactorial, team-based and involve the patients' families and carers. Much of the research regarding the management and treatment of dysphagia in general is in its infancy: larger and more rigorous studies are required to demonstrate treatment efficacy. More studies specifically examining dysphagia and its management in the TBI population are required to ensure the future efficacy and accuracy of treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.